Valvular & structural heart disease

Left Ventricular Hypertrophy as a Predictor of Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement

ESC Heart FailPublished Retrospective cohort study

Authors' conclusion

Severe LVH before TAVR is a prognostic factor for poor post-operative cardiovascular outcomes. LVH associated with aortic stenosis and CSN function are correlated, suggesting their involvement in LVH prognosis.

Study context

Population
Patients with severe AS who underwent transcatheter aortic valve replacement (TAVR), July 2017–May 2020
Participants
349 patients
Exposure
Severe left ventricular hypertrophy (LVH) vs no LVH before TAVR
Outcome
Freedom from CV events (CV death and HF hospitalization)
Methodological detailssingle-centre
  • Single-centre

Main finding

As reported in the abstract

Event-free rate

P = 0.021

Observational data: associations, not effects.

Further findings

OutcomeValuesP value
Delay H/M (123I-MIBG), pre-TAVRSevere LVH (+) vs Severe LVH (-)Severe LVH (+) 2.33 (range 1.92–2.67) · Severe LVH (-) 2.67 (range 2.17–3.68)P < 0.001
Event-free rate by delay H/MDelay H/M < 2.50 vs Other patients · log-rankDelay H/M < 2.50 87.7% · Other patients 97.2%P = 0.012
LVMi · 6 months after TAVRSevere LVH (+) vs Severe LVH (-)Severe LVH (+) 115 (range 99–130) g/m² · Severe LVH (-) 90 (range 78–111) g/m²P < 0.001
Delay H/M · 6 months after TAVRSevere LVH (+) vs Severe LVH (-)Severe LVH (+) 2.53 (range 1.98–2.83) · Severe LVH (-) 2.71 (range 2.25–3.19)P = 0.025

Change in delay H/M by LVH improvement at 6 months · 6 months after TAVR

Improved LVH: delay H/M from 2.51 [2.01-2.81] to 2.67 [2.26-3.02]
P < 0.001
No improved LVH: delay H/M from 2.64 [2.23-3.06] to 2.53 [1.97-3.00], no significant change
P = 0.829

Original publication

Left Ventricular Hypertrophy as a Predictor of Cardiovascular Outcomes After Transcatheter Aortic Valve Replacement. ESC Heart Fail. Published 1 February 2023. doi:10.1002/ehf2.14305

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.